Bullish on IPOs

April 2007
Red Herring;4/16/2007, Vol. 4 Issue 14, p6
Trade Publication
The article presents information on the success achieved by venture-backed initial public offerings (IPOs) in the first quarter of 2007. According to the latest Exit Poll report from Thomson Financial and the National Venture Capital Association, 17 venture-backed firms raised 52.09 billion, a 70 percent increase from the year-ago quarter. According to Dow Jones & Co.'s VentureOne research, these IPOs were dominated by information technology firms, and the top performers were largely telecom-related. The market also favored medical device makers like Xtent Inc. and SenoRx Inc.


Related Articles

  • SenoRx files IPO to raise up to $59M to commercialize EnCor. Johnson, Holland // Medical Device Daily;3/28/2007, Vol. 11 Issue 59, p1 

    The article reports on the decision of SenoRx to file an initial public offering (IPO) of its stock. The company which manufactures biopsy systems and breast tissue markers used in the diagnosis and treatment of breast cancer, has filed to sell 5.5 million shares at $11 to $13 per share. It...

  • THE IPO 100.  // Investment Dealers' Digest;9/25/2006, Vol. 72 Issue 36, p33 

    Several charts are presented that lists the stocks of financial companies in the U.S. for 2006 including a review of the top 100 public offerings made by companies, the number of initial public offerings &x0026; filing and the overview of the initial public offerings taken from Thomson Financial.

  • DEVICE DEBUTS: Biomed Companies Test IPO Waters; Profits Still to Come. Reed, Vita // Orange County Business Journal;6/12/2006, Vol. 29 Issue 24, p1 

    The article reports on the decision of Alsius Corp. and SenoRx Inc., two medical instrument manufacturers, to file plans for initial public offerings in the U.S. The main objective of these companies is to raise $215 million. Alsius Corp. is planning to sell about $40 million and SenoRx Inc....

  • State lags in VC-backed IPOs. Henderson, Tom // Crain's Detroit Business;7/9/2007, Vol. 23 Issue 28, p2 

    The article informs that the National Venture Capital Association has released its figures for VC-backed companies that went public nationally in the second quarter and for the second straight quarter. It is stated that no Michigan firm has made the list. But, California had nine Initial Public...

  • HEALTHCARE. Gomez, Alisha // Orange County Business Journal;4/23/2007, Vol. 30 Issue 17, p9 

    The article reports on the plan of medical instruments manufacturer Masimo Corp. to issue an initial public offering to raise $150 million in Irvine, California. According to the company, the proceeds of the public offering will be used to fund ongoing research and development and sales and...

  • Uncertainty in regulatory process hinders med-tech funding efforts. FORD, OMAR // Medical Device Daily;11/8/2011, Vol. 15 Issue 214, p1 

    The article focuses on a report from PricewaterhouseCoopers LLP (PwC)/National Venture Capital Association which highlighted a decline in the number of U.S. medical-technology deals in the third quarter of 2011. According to the report, the industry posted a 17% growth but its number of deals...

  • Finance in brief. Soule, Alexander // Fairfield County Business Journal;8/9/2010, Vol. 49 Issue 32, p2 

    The article offers news briefs in Connecticut related to finance including the Money Tree report by the National Venture Capital Association that projected a venture capital gain of 24.5 million U.S. dollar among 16 Connecticut firms in the second quarter of 2010 and the increased in seed...

  • SciQuest Files for IPO Again. Red Herring Staff // Red Herring;3/25/2010, p1 

    The article reports that SciQuest, a maker of Internet-based supply chain and procurement software, has filed for an initial public offering (IPO) following its privatization in 2004. The Cary, North Carolina-based company aims to gather up to 75 million U.S. dollars from the IPO. In 2009, the...

  • NeurogesX Lowers Share Price, Brings In $44M.  // Bioworld Week;5/7/2007, Vol. 15 Issue 19, p4 

    The article reports on the decreased of NeurogesX Inc.'s initial public offering of 4 million shares at $9 each for gross proceeds of $44 million in the U.S. It is stated that the price fell below the $13 to $15 price range when the company amended its offering terms. Moreover, on the day of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics